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Introduction
Between January 2011 and July 2014, we performed a
Randomized Controlled Trial (RCT) in carriers of
methicillin-resistant Staphylococcus aureus (MRSA) to
test the efficacy of polyhexanide versus a placebo solu-
tion for MRSA decolonization.
Objectives
We assessed determinants associated with successful
MRSA decolonization among patients included in this
RCT.
Methods
We conducted a retrospective, unmatched case-control
study among MRSA-positive patients treated by polyhexa-
nide or placebo and a MRSA screening swab at day 28
after the end of the treatment. Cases were defined as
patients with a negative MRSA screening at the end of the
study. The control group consisted of patients still MRSA-
positive at the end of the study. We tested potential pro-
moting factors using univariate logistic regression analysis.
Data were recorded prospectively during the initial RCT
with the consent of the patients. A multivariate logistic
regression model was then built. We kept as potential can-
didates for the multivariate analysis promoting factors
with a p-value < 0.2. The resulting model was verified
using the Hosmer-Lemeshow test.
Results
A total of 135 patients were identified: 46 MRSA-negative
cases (34.1%) and 89 MRSA-positive controls (65.9%) at
end of follow-up. Cases were younger (Odds Ratio (OR)
per 1-year increment; 0.98, P=0.079), lived without
assistance (OR 2.97, P=0.005), had only the nose or groin
colonized (OR 2.30, P=0.023), had no invasive devices (OR
2.53, P=0.065) and a length of hospital stay until first day
of decolonization treatment of ≤ 3 weeks (OR 2.42,
P=0.04), were more likely to be without malignancy (OR
2.66, P=0.073) or COPD (OR 2.23, P=0.119) compared to
the control group. By multivariate analysis, two indepen-
dent factors were associated with successful MRSA
decolonization: independent status (OR 2.83, 95%CI
[1.26-6.34], P=0.011) and only one colonized body site at
baseline (OR 2.16, 95%CI [1.03-4.56], P=0.042; Hosmer-
Lemeshow test, P=0.45).
Conclusion
Independent patients with only 1 MRSA-positive body
site at baseline (nose or groin) are more likely to be suc-
cessfully decolonized.
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